NR2B- and NR2D-containing synaptic NMDA receptors in developing rat substantia nigra pars compacta dopaminergic neurones

S. L.C. Brothwell, J. L. Barber, D. T. Monaghan, D. E. Jane, A. J. Gibb, S. Jones

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

NMDA receptors are present at glutamatergic synapses throughout the brain, and are important for the development and plasticity of neural circuits. Their subunit composition is developmentally regulated. We have investigated the developmental profile of functional synaptic NMDA receptor subunits in dopaminergic neurones of the substantia nigra pars compacta (SNc). In SNc dopaminergic neurones from rats aged postnatal day (P)7, ifenprodil inhibited NMDA-EPSCs with an estimated IC50 of 0.36 μM and a maximum inhibition of 73.5 ± 2.7% (10 μM), consistent with a substantial population of NR1/ NR2B-containing diheteromeric receptors. UBP141, a novel NR2D-preferring antagonist, inhibited NMDA-EPSCs with an estimated IC50 of 6.2 μM. During postnatal development, the maximum inhibitory effect of 10 μM ifenprodil significantly decreased. However, NMDA-EPSCs were not inhibited by Zn2+ (200 nM) or potentiated by the Zn2+ chelator TPEN (1 μM), and the effect of UBP141 did not increase during development, indicating that NR2B subunits are not replaced with diheteromeric NR2A or NR2D subunits. The time course of the decay of NMDA-EPSCs was not significantly changed in ifenprodil at any age tested. Together, these data suggest that diheteromeric NR1/NR2A or NR1/NR2D receptors do not account for the ifenprodil-resistant component of the NMDA-EPSC. We propose that NR1/NR2B/NR2D triheteromers form a significant fraction of synaptic NMDA receptors during postnatal development. This is the first report of data suggesting NR2D-containing triheteromeric NMDA receptors at a brain synapse.

Original languageEnglish (US)
Pages (from-to)739-750
Number of pages12
JournalJournal of Physiology
Volume586
Issue number3
DOIs
StatePublished - Feb 1 2008

Fingerprint

Neurotransmitter Receptor
Dopaminergic Neurons
N-Methylaspartate
N-Methyl-D-Aspartate Receptors
Synapses
Inhibitory Concentration 50
Neuronal Plasticity
Brain
Chelating Agents
Pars Compacta
ifenprodil
Population

ASJC Scopus subject areas

  • Physiology

Cite this

NR2B- and NR2D-containing synaptic NMDA receptors in developing rat substantia nigra pars compacta dopaminergic neurones. / Brothwell, S. L.C.; Barber, J. L.; Monaghan, D. T.; Jane, D. E.; Gibb, A. J.; Jones, S.

In: Journal of Physiology, Vol. 586, No. 3, 01.02.2008, p. 739-750.

Research output: Contribution to journalArticle

Brothwell, S. L.C. ; Barber, J. L. ; Monaghan, D. T. ; Jane, D. E. ; Gibb, A. J. ; Jones, S. / NR2B- and NR2D-containing synaptic NMDA receptors in developing rat substantia nigra pars compacta dopaminergic neurones. In: Journal of Physiology. 2008 ; Vol. 586, No. 3. pp. 739-750.
@article{e985c13e27c34b02b4b700c202d8026a,
title = "NR2B- and NR2D-containing synaptic NMDA receptors in developing rat substantia nigra pars compacta dopaminergic neurones",
abstract = "NMDA receptors are present at glutamatergic synapses throughout the brain, and are important for the development and plasticity of neural circuits. Their subunit composition is developmentally regulated. We have investigated the developmental profile of functional synaptic NMDA receptor subunits in dopaminergic neurones of the substantia nigra pars compacta (SNc). In SNc dopaminergic neurones from rats aged postnatal day (P)7, ifenprodil inhibited NMDA-EPSCs with an estimated IC50 of 0.36 μM and a maximum inhibition of 73.5 ± 2.7{\%} (10 μM), consistent with a substantial population of NR1/ NR2B-containing diheteromeric receptors. UBP141, a novel NR2D-preferring antagonist, inhibited NMDA-EPSCs with an estimated IC50 of 6.2 μM. During postnatal development, the maximum inhibitory effect of 10 μM ifenprodil significantly decreased. However, NMDA-EPSCs were not inhibited by Zn2+ (200 nM) or potentiated by the Zn2+ chelator TPEN (1 μM), and the effect of UBP141 did not increase during development, indicating that NR2B subunits are not replaced with diheteromeric NR2A or NR2D subunits. The time course of the decay of NMDA-EPSCs was not significantly changed in ifenprodil at any age tested. Together, these data suggest that diheteromeric NR1/NR2A or NR1/NR2D receptors do not account for the ifenprodil-resistant component of the NMDA-EPSC. We propose that NR1/NR2B/NR2D triheteromers form a significant fraction of synaptic NMDA receptors during postnatal development. This is the first report of data suggesting NR2D-containing triheteromeric NMDA receptors at a brain synapse.",
author = "Brothwell, {S. L.C.} and Barber, {J. L.} and Monaghan, {D. T.} and Jane, {D. E.} and Gibb, {A. J.} and S. Jones",
year = "2008",
month = "2",
day = "1",
doi = "10.1113/jphysiol.2007.144618",
language = "English (US)",
volume = "586",
pages = "739--750",
journal = "Journal of Physiology",
issn = "0022-3751",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - NR2B- and NR2D-containing synaptic NMDA receptors in developing rat substantia nigra pars compacta dopaminergic neurones

AU - Brothwell, S. L.C.

AU - Barber, J. L.

AU - Monaghan, D. T.

AU - Jane, D. E.

AU - Gibb, A. J.

AU - Jones, S.

PY - 2008/2/1

Y1 - 2008/2/1

N2 - NMDA receptors are present at glutamatergic synapses throughout the brain, and are important for the development and plasticity of neural circuits. Their subunit composition is developmentally regulated. We have investigated the developmental profile of functional synaptic NMDA receptor subunits in dopaminergic neurones of the substantia nigra pars compacta (SNc). In SNc dopaminergic neurones from rats aged postnatal day (P)7, ifenprodil inhibited NMDA-EPSCs with an estimated IC50 of 0.36 μM and a maximum inhibition of 73.5 ± 2.7% (10 μM), consistent with a substantial population of NR1/ NR2B-containing diheteromeric receptors. UBP141, a novel NR2D-preferring antagonist, inhibited NMDA-EPSCs with an estimated IC50 of 6.2 μM. During postnatal development, the maximum inhibitory effect of 10 μM ifenprodil significantly decreased. However, NMDA-EPSCs were not inhibited by Zn2+ (200 nM) or potentiated by the Zn2+ chelator TPEN (1 μM), and the effect of UBP141 did not increase during development, indicating that NR2B subunits are not replaced with diheteromeric NR2A or NR2D subunits. The time course of the decay of NMDA-EPSCs was not significantly changed in ifenprodil at any age tested. Together, these data suggest that diheteromeric NR1/NR2A or NR1/NR2D receptors do not account for the ifenprodil-resistant component of the NMDA-EPSC. We propose that NR1/NR2B/NR2D triheteromers form a significant fraction of synaptic NMDA receptors during postnatal development. This is the first report of data suggesting NR2D-containing triheteromeric NMDA receptors at a brain synapse.

AB - NMDA receptors are present at glutamatergic synapses throughout the brain, and are important for the development and plasticity of neural circuits. Their subunit composition is developmentally regulated. We have investigated the developmental profile of functional synaptic NMDA receptor subunits in dopaminergic neurones of the substantia nigra pars compacta (SNc). In SNc dopaminergic neurones from rats aged postnatal day (P)7, ifenprodil inhibited NMDA-EPSCs with an estimated IC50 of 0.36 μM and a maximum inhibition of 73.5 ± 2.7% (10 μM), consistent with a substantial population of NR1/ NR2B-containing diheteromeric receptors. UBP141, a novel NR2D-preferring antagonist, inhibited NMDA-EPSCs with an estimated IC50 of 6.2 μM. During postnatal development, the maximum inhibitory effect of 10 μM ifenprodil significantly decreased. However, NMDA-EPSCs were not inhibited by Zn2+ (200 nM) or potentiated by the Zn2+ chelator TPEN (1 μM), and the effect of UBP141 did not increase during development, indicating that NR2B subunits are not replaced with diheteromeric NR2A or NR2D subunits. The time course of the decay of NMDA-EPSCs was not significantly changed in ifenprodil at any age tested. Together, these data suggest that diheteromeric NR1/NR2A or NR1/NR2D receptors do not account for the ifenprodil-resistant component of the NMDA-EPSC. We propose that NR1/NR2B/NR2D triheteromers form a significant fraction of synaptic NMDA receptors during postnatal development. This is the first report of data suggesting NR2D-containing triheteromeric NMDA receptors at a brain synapse.

UR - http://www.scopus.com/inward/record.url?scp=38849204753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38849204753&partnerID=8YFLogxK

U2 - 10.1113/jphysiol.2007.144618

DO - 10.1113/jphysiol.2007.144618

M3 - Article

C2 - 18033813

AN - SCOPUS:38849204753

VL - 586

SP - 739

EP - 750

JO - Journal of Physiology

JF - Journal of Physiology

SN - 0022-3751

IS - 3

ER -